These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 19643357

  • 1. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH.
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [Abstract] [Full Text] [Related]

  • 2. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
    Sarkar S, Hettrick DA, Koehler J, Rogers T, Grinberg Y, Yu CM, Abraham WT, Small R, Tang WH.
    J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
    [Abstract] [Full Text] [Related]

  • 3. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM, PARTNERS Study Investigators.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1803-10. PubMed ID: 20413029
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B, European InSync Sentry Observational Study Investigators.
    Eur Heart J; 2007 Aug 27; 28(15):1835-40. PubMed ID: 17309902
    [Abstract] [Full Text] [Related]

  • 5. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP.
    Circulation; 2005 Aug 09; 112(6):841-8. PubMed ID: 16061743
    [Abstract] [Full Text] [Related]

  • 6. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
    Vanderheyden M, Houben R, Verstreken S, Ståhlberg M, Reiters P, Kessels R, Braunschweig F.
    Circ Heart Fail; 2010 May 09; 3(3):370-7. PubMed ID: 20197559
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M, DOT-HF Investigators.
    Circulation; 2011 Oct 18; 124(16):1719-26. PubMed ID: 21931078
    [Abstract] [Full Text] [Related]

  • 9. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
    Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, Perego GB, Varbaro A, Denaro A, Valsecchi S, Vergara G, Italian Clinical Service Optivol-CRT Group.
    Pacing Clin Electrophysiol; 2009 Mar 18; 32(3):363-70. PubMed ID: 19272067
    [Abstract] [Full Text] [Related]

  • 10. Uncovering interim clinical events at the time of clinical encounter by reviewing intrathoracic impedance threshold crossings.
    Tang WH, Wickemeyer WJ, Germany RE, Hoppe BL, Andriulli JA, Brady PA, Sarkar S, Hettrick DA, Small RS.
    J Card Fail; 2011 Nov 18; 17(11):893-8. PubMed ID: 22041325
    [Abstract] [Full Text] [Related]

  • 11. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
    Cowie MR, Conraads V, Tavazzi L, Yu CM, SENSE-HF Investigators.
    J Card Fail; 2009 Jun 18; 15(5):394-400. PubMed ID: 19477399
    [Abstract] [Full Text] [Related]

  • 12. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O'Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, Bristow MR.
    Circulation; 2009 Feb 24; 119(7):969-77. PubMed ID: 19204305
    [Abstract] [Full Text] [Related]

  • 13. Intrathoracic impedance monitoring to predict decompensated heart failure.
    Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van Erven L.
    Am J Cardiol; 2007 Feb 15; 99(4):554-7. PubMed ID: 17293202
    [Abstract] [Full Text] [Related]

  • 14. Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.
    Whellan DJ, Droogan CJ, Fitzpatrick J, Adams S, McCarey MM, Andrel J, Mather P, Rubin S, Bonita R, Keith S.
    J Card Fail; 2012 Feb 15; 18(2):107-12. PubMed ID: 22300777
    [Abstract] [Full Text] [Related]

  • 15. Single center experience with intrathoracic impedance monitoring.
    Qiao Q, Hua W, Ding LG, Chen KP, Wang J, Wang FZ, Zhang S.
    Chin Med J (Engl); 2011 Jul 15; 124(14):2219-21. PubMed ID: 21933630
    [Abstract] [Full Text] [Related]

  • 16. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).
    Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA, FAST Study Investigators.
    Congest Heart Fail; 2011 Jul 15; 17(2):51-5. PubMed ID: 21449992
    [Abstract] [Full Text] [Related]

  • 17. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L.
    Am J Cardiol; 2007 May 21; 99(10A):3G-10G. PubMed ID: 17512421
    [Abstract] [Full Text] [Related]

  • 18. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.
    Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A, Rhodes MM, InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators.
    Circulation; 2004 Oct 19; 110(16):2389-94. PubMed ID: 15313946
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR.
    Eur Heart J; 2011 Sep 19; 32(18):2266-73. PubMed ID: 21362703
    [Abstract] [Full Text] [Related]

  • 20. A critical link between heart failure self-care and intrathoracic impedance.
    Rathman LD, Lee CS, Sarkar S, Small RS.
    J Cardiovasc Nurs; 2011 Sep 19; 26(4):E20-6. PubMed ID: 21076309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.